PAREXEL International Mergers and Acquisitions Summary

Life Science Company

PAREXEL International has acquired 16 companies of its own, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.

PAREXEL International’s largest acquisition to date was in 2012, when it acquired Liquent for $72M. PAREXEL International has acquired in 5 different US states, and 5 countries. The Company’s most targeted sectors include life science (57%) and business services (13%).

Join Mergr and gain access to PAREXEL International’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity17
    • M&A Buy Activity16
    • M&A Sell Activity1
  • Total Sectors Invested 6
  • Total Countries Invested 5
  • M&A Buy/Sell Connections 3
  • M&A Advisors 1

PAREXEL International Corp.

195 West Street,
Waltham, Massachusetts 02451
United States,
(781) 487-9900
www.parexel.com

PAREXEL International Corp. is a global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the integrated clinical development and regulatory information management process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 86 locations in 51 countries around the world, and has approximately 19,600 employees.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.6/yr) # 13 2 1 - - - 16
vol $176M $176M
Sell (0.0/yr) # 1 - - - - - 1
  17

Most Recent M&A

Company Date Value Type
The Medical Affairs Co. LLC 2017-02-01 - Add-on Acquisition
Kennesaw, Georgia · www.themedicalaffairscompany.com
ExecuPharm, Inc. 2016-09-26 - Add-on Acquisition
King of Prussia, Pennsylvania · www.execupharm.com
Health Advances LLC 2016-01-19 - Add-on Acquisition
Weston, Massachusetts · www.healthadvances.com
ClinIntel Ltd. 2014-10-03 - Add-on Acquisition
Crawley, United Kingdom · www.clinintel.com
ATLAS Medical Services Ltd. 2014-07-01 - Add-on Acquisition
Istanbul, Turkey · www.atlas-cro.com
HERON Group Ltd. 2013-04-30 38M USD Add-on Acquisition
Luton, United Kingdom · www.heronhealth.com
Liquent, Inc. 2012-12-21 72M USD Add-on Acquisition
Horsham, Pennsylvania · www.liquent.com
ClinPhone plc 2008-08-14 - Add-on Acquisition
Nottingham, United Kingdom · www.clinphone.com
Barnett International 2008-04-03 - Divestiture
Centreville, Virginia · www.barnettinternational.com
APEX International Clinical Research Co. Ltd. 2007-09-26 51M USD Add-on Acquisition
Taipei, Taiwan
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Perceptive Informatics, Inc. 2000-10-19 Invantage, Inc. 2002-09-10 1
Birmingham, United Kingdom Cambridge, Massachusetts

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 9 (56%) 89M (50%) - -
Business Services 2 (13%) - 1 (100%) -
Software 2 (13%) 87M (50%) - -
Information Technology 1 (6%) - - -
Internet Software and Services 1 (6%) - - -
Marketing 1 (6%) - - -
Total 16 $176M 1 -

By Geo

State/Country Buy Value Sell Value
United States 8 72M 1 -
  California 3 - - -
  Pennsylvania 2 72M - -
  Massachusetts 1 - - -
  Georgia 1 - - -
  Virginia - - 1 -
United Kingdom 5 53M - -
Germany 1 - - -
Taiwan 1 51M - -
Turkey 1 - - -
Domestic 8 (50%) 72M (41%) 1 (100%) -
Cross-border 8 (50%) 104M (59%) - -
Total 16 $176M 1 -

Top M&A Advisors

Financial Deals
Agile Equity LLC
1

Deal Values

buy # Total
< $100M 4 $176M
TOTAL $176M
Largest Liquent, Inc.
$72M (2012-12-21)

M&A Connections

Deals %
Acquired from
PE Firm(s)
50%
1 50%
Strategic(s)
50%
1 50%
Divested to
Strategic(s)
100%
1 100%

 Subscribe to unlock this and 150,071
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.9K Private Equity Firms
  • 137K M&A Transactions
  • 146K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 39K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.